Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
230.29+3.37 (+1.49%)
At close: 4:00PM EDT
230.00 -0.29 (-0.13%)
Pre-market: 08:27AM EDT
Pre-market: 08:27AM EDT
| Previous close | 226.92 |
| Open | 227.89 |
| Bid | 230.00 x 1100 |
| Ask | 230.60 x 1800 |
| Day's range | 223.00 - 231.87 |
| 52-week range | 76.59 - 331.68 |
| Volume | 2,867,640 |
| Avg. volume | 4,867,593 |
| Market cap | 17.153B |
| Beta (5Y monthly) | 1.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -13.84 |
| Earnings date | 08 Nov 2021 - 12 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 264.20 |
- Editor's pickYahoo Finance Video
‘Absolutely’ a future where everyone's DNA sequenced at birth: 23andMe CEO
23andMe Co-Founder & CEO Anne Wojcicki joins 'Influencers with Andy Serwer' to discuss the future of personal genomics.
- Editor's pickYahoo Finance Video
Could natural COVID-19 immunity trump vaccine mandates?
Yahoo Finance's Alexis Keenan provides the latest on how businesses are handling the COVID-19 vaccine mandate.
- Motley Fool
September Sell-Off: Best Stocks to Buy Now
Chinese real estate giant China Evergrande Group has warned it might default on debt. First on my list is Novavax (NASDAQ: NVAX). The company might be the next to enter the coronavirus vaccine market.
© 2021 Verizon Media. All rights reserved.
